LongBio Pharma (Suzhou) Co., Ltd. (01779)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Kan | 19-May-25 | Non-executive Director | |||
| 31-Aug-26 | NED | To devote more time to other business commitments | |||
| Gu Qin | 20-Oct-22 | MbNC | |||
| Lin Jian | 20-Oct-22 | MbAC | |||
| Liu Heng | 26-Oct-20 | Ch, ED, CEO, GM, ChNC | |||
| Ruan Tim | 15-Aug-25 | INED, MbAC, MbCC | |||
| Siu Paul Yu Hay | 15-Aug-25 | INED, ChAC, MbNC | |||
| Sun Bill Nai-Chau | 05-Jun-26 | ED, Co-Fdr | |||
| Xie Ming | 19-May-25 | ED, Dep GM, AuRep, MbCC | |||
| Xue Di | 19-May-25 | Non-executive Director | |||
| Xue Kailu | 10-Sep-26 | Non-executive Director | |||
| Yang Chun | 15-Aug-25 | INED, ChCC, MbNC | |||
| Yung Mei Yee | 29-Jul-25 | CoSec, AuRep | |||
| Zhou Guofang | 15-Aug-25 | INED, MbNC |